Appropriate Use of Idarucizumab for Dabigatran Reversal According to the International Society on Thrombosis and Hemostasis and French Working Group on Perioperative Hemostasis: A French Retrospective Study.

Nicolas Gendron Richard Chocron Aurélien Philippe Christine Le Beller Agnès Lillo-le Louët David M Smadja

J Cardiothorac Vasc Anesth

Université de Paris, Innovative Therapies in Hemostasis, INSERM; Hematology Department and Biosurgical Research Lab, (Carpentier Foundation) Assistance Publique Hôpitaux de Paris, Centre-Université de Paris (APHP-CUP), 75015, Paris, France; F-CRIN INNOVTE, Saint-Étienne, France.

Published: October 2021

Download full-text PDF	Source
http://dx.doi.org/10.1053/j.jvca.2021.02.029	DOI Listing

Publication Analysis

Top Keywords

hemostasis french

appropriate idarucizumab

idarucizumab dabigatran

dabigatran reversal

reversal international

international society

society thrombosis

thrombosis hemostasis

french working

working group

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!